GO:0051129 negative regulation of cellular component organization: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051129 describes any process that stops, prevents, or reduces the frequency, rate, or extent of cellular component organization, including formation, arrangement, disassembly of cell structures, plasma membrane, and external encapsulating structures.
• This term is a biological process node that integrates inhibitory signals across cytoskeletal remodeling, membrane trafficking, and extracellular matrix assembly.
• Key regulatory proteins include paxillin (PXN), which scaffolds focal adhesion disassembly, and CCN1 (CYR61), which modulates collagen alignment and scar integrity.
• Dysregulation of negative regulation of cellular component organization contributes to cancer progression, impaired wound healing, and neuromuscular disorders.
• Experimental dissection relies on CRISPR knockout, point mutation, knock-in, overexpression models combined with imaging, proteomics, and transcriptomics.
• The term is distinct from positive regulation and is often studied alongside Notch, circadian chromatin, and tumor-immune microenvironment remodeling.
Description
GO:0051129, negative regulation of cellular component organization, is a Gene Ontology biological process term that captures any mechanism which stops, prevents, or reduces the frequency, rate, or extent of processes involved in the formation, arrangement, disassembly, or maintenance of cell structures, including the plasma membrane and external encapsulating structures such as the cell wall and cell envelope. This term is essential for understanding how cells dynamically control their architecture, from focal adhesion turnover to extracellular matrix remodeling, and how these inhibitory checkpoints are subverted in disease. Researchers studying this process investigate how cells terminate or dampen organizational events, which is critical for normal development, tissue homeostasis, and immune responses. The term encompasses diverse molecular players, including scaffolding proteins like paxillin and matricellular proteins like CCN1, which coordinate the timing and location of structural disassembly. Because negative regulation of cellular component organization is often hijacked in cancer, fibrosis, and neuromuscular disorders, it represents a rich area for therapeutic target discovery and CRISPR-based functional genomics.
negative regulation of cellular component organization At A Glance
| GO ID | GO:0051129 |
|---|---|
| GO term | negative regulation of cellular component organization |
| Ontology | biological_process |
| Synonym | down regulation of cell organization; down-regulation of cell organization; downregulation of cell organization; inhibition of cell organization; negative regulation of cell organisation; negative regulation of cellular component organization and biogenesis |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of cellular component organization, including formation, arrangement, disassembly of cell structures, plasma membrane, and external encapsulating structures |
| Related processes | Cytoskeletal remodeling, focal adhesion turnover, extracellular matrix assembly, membrane trafficking |
| Example regulators | PXN (paxillin), CCN1 (CYR61), Notch signaling components, circadian chromatin modifiers |
| Disease relevance | Cancer, impaired wound healing, neuromuscular disorders, immune evasion |
What Is GO:0051129?
In our own words, GO:0051129 refers to any biological process that inhibits, delays, or reduces the frequency, rate, or extent of cellular component organization. This includes blocking the formation, arrangement, or disassembly of cell structures such as the plasma membrane, cytoskeleton, organelles, and external encapsulating structures like the cell wall or cell envelope. It is a negative regulatory node that ensures organizational events are properly timed and terminated, preventing excessive or aberrant structural assembly.
Why Is negative regulation of cellular component organization Important in Cell Biology?
Negative regulation of cellular component organization is critically important because it provides the brakes that prevent uncontrolled structural assembly or disassembly, which would otherwise lead to pathological states such as tumor invasion, fibrosis, or muscle degeneration. Understanding this process helps researchers identify therapeutic targets and design experiments to modulate cellular architecture in disease models.
• Controls focal adhesion disassembly and cell migration, impacting cancer metastasis.
• Regulates extracellular matrix remodeling and scar integrity after myocardial infarction.
• Modulates immune cell organization within the tumor microenvironment.
• Influences sensory nerve regulation of tertiary lymphoid structures in melanoma.
• Affects circadian chromatin organization and gene expression rhythms.
• Plays a role in Notch signaling dysregulation in cervical cancer.
• Contributes to muscle satellite cell dysfunction in neuromuscular disorders.
• Provides a framework for understanding primary atopic disorders via genomic sequencing.
• Serves as a target for CRISPR-based functional screens to identify novel regulators.
• Helps explain how cells terminate organizational events during development and homeostasis.
What Happens During negative regulation of cellular component organization?
Initiation of inhibitory signals
In simple terms: Cells receive signals that tell them to stop building or breaking down structures.
Negative regulation of cellular component organization begins when specific molecular cues, such as phosphorylation events or protein-protein interactions, activate inhibitory pathways. For example, paxillin interactions can recruit phosphatases or kinases that block focal adhesion assembly, thereby reducing cell spreading and migration. Similarly, circadian chromatin regulators can repress the expression of genes required for cytoskeletal organization, dampening structural remodeling at specific times of day.
Execution of disassembly or prevention
In simple terms: The cell actively dismantles or prevents the formation of structures like focal adhesions or collagen fibers.
Once inhibitory signals are engaged, effector proteins execute disassembly or block assembly. CCN1 (CYR61) promotes collagen alignment and scar integrity after myocardial infarction, but its negative regulatory role can also limit excessive fibrosis by modulating matrix metalloproteinase activity and integrin signaling. In the tumor microenvironment, negative regulation of cellular component organization can prevent the formation of tertiary lymphoid structures, as seen when sensory nerves impede protective antimelanoma immune responses.
Feedback and termination
In simple terms: The process shuts itself off to avoid completely halting all structural changes.
Feedback loops ensure that negative regulation is transient and context-dependent. For instance, Notch signaling in cervical cancer can both promote and inhibit cellular organization depending on the cellular context, with negative regulation occurring through repression of target genes involved in cytoskeletal rearrangement. This feedback prevents permanent structural paralysis and allows cells to respond to new environmental cues.
Integration with immune and tissue remodeling
In simple terms: The process influences how immune cells organize within tissues and how scars form.
Negative regulation of cellular component organization is integrated with immune responses and tissue repair. In triple negative breast cancer, multiplexed ion beam imaging revealed that the tumor-immune microenvironment is structured by spatial organization processes that are subject to negative regulation, affecting immune cell infiltration and function. Similarly, in neuromuscular disorders, muscle satellite cell dysfunction involves impaired negative regulation of cellular component organization, leading to failed regeneration.
Key Genes Involved in GO:0051129 negative regulation of cellular component organization
The following genes and proteins are experimentally implicated in negative regulation of cellular component organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PXN | Scaffolding protein at focal adhesions; regulates disassembly | Studied for cell migration and cancer invasion |
| CCN1 (CYR61) | Matricellular protein; modulates collagen alignment and scar integrity | Investigated in myocardial infarction and fibrosis |
| NOTCH1 | Signaling receptor; context-dependent regulation of cellular organization | Linked to cervical cancer progression |
| PER1 | Circadian clock protein; regulates chromatin organization | Studied in circadian rhythm and gene expression |
| CRY1 | Circadian repressor; affects chromatin remodeling | Investigated in circadian chromatin regulation |
| CLOCK | Transcription factor; controls circadian gene expression | Studied in circadian organization of chromatin |
| BMAL1 | Core clock transcription factor; regulates rhythmic organization | Investigated in circadian biology |
| CDH1 | Cell adhesion molecule; negative regulation of junction disassembly | Studied in cancer and epithelial organization |
| VIM | Intermediate filament; regulated disassembly during migration | Investigated in cell migration and cancer |
| ACTN1 | Actin crosslinking protein; modulates cytoskeletal organization | Studied in focal adhesion dynamics |
| TLN1 | Focal adhesion protein; regulates adhesion turnover | Investigated in cell migration |
| ITGB1 | Integrin beta 1; controls matrix adhesion and disassembly | Studied in extracellular matrix organization |
| MMP2 | Matrix metalloproteinase; degrades extracellular matrix | Investigated in scar formation and cancer |
| MMP9 | Matrix metalloproteinase; regulates matrix remodeling | Studied in immune cell infiltration |
| CCL21 | Chemokine; involved in lymphoid structure organization | Investigated in tertiary lymphoid structures |
| LTBR | Lymphotoxin beta receptor; regulates lymphoid organization | Studied in immune microenvironment |
| PDPN | Podoplanin; regulates lymphatic and stromal organization | Investigated in tumor microenvironment |
How Is negative regulation of cellular component organization Regulated?
Negative regulation of cellular component organization is itself regulated by upstream signaling pathways including circadian clock components, Notch signaling, and integrin-mediated adhesion. Circadian chromatin regulators such as PER1 and CRY1 repress the expression of genes involved in cytoskeletal organization, thereby imposing temporal control. Notch signaling can inhibit cellular organization by repressing target genes required for cytoskeletal rearrangement in cervical cancer cells. Additionally, paxillin phosphorylation and focal adhesion kinase activity modulate the recruitment of inhibitory proteins that block adhesion assembly. These regulatory layers ensure that negative regulation is context-specific and reversible.
negative regulation of cellular component organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PXN | Cancer metastasis and cell migration | Knockout and point mutation in cancer cell lines |
| CCN1 | Myocardial infarction and fibrosis | Knock-in and overexpression in cardiac fibroblasts |
| NOTCH1 | Cervical cancer | Knockout and overexpression in cervical cancer cells |
| PER1 | Circadian rhythm disruption | Knockout in circadian reporter cell lines |
| CCL21 | Melanoma immune evasion | Knockout in melanoma mouse models |
Cancer progression and immune evasion
Dysregulated negative regulation of cellular component organization contributes to cancer progression by allowing tumor cells to evade immune surveillance and invade surrounding tissues. In triple negative breast cancer, the tumor-immune microenvironment is spatially organized by processes subject to negative regulation, and disruption of these inhibitory signals can enhance immune cell infiltration. Sensory nerves impede the formation of tertiary lymphoid structures and protective antimelanoma immune responses, highlighting how negative regulation of cellular organization can suppress antitumor immunity. Notch signaling dysregulation in cervical cancer further illustrates how loss of negative regulation promotes malignant phenotypes.
Cardiovascular fibrosis and wound healing
CCN1 (CYR61) promotes collagen alignment and scar integrity after myocardial infarction, but excessive or insufficient negative regulation of cellular component organization can lead to pathological fibrosis or scar rupture. The balance between matrix deposition and disassembly is critical for proper wound healing, and dysregulation of this process contributes to cardiac remodeling and heart failure.
Neuromuscular disorders
Muscle satellite cell dysfunction in neuromuscular disorders involves impaired negative regulation of cellular component organization, leading to failed muscle regeneration and progressive weakness. Understanding how satellite cells terminate organizational events during activation and differentiation may reveal therapeutic targets for conditions such as muscular dystrophy.
Primary atopic disorders
Rapid identification of primary atopic disorders through clinical landmark-guided genomic sequencing has revealed that defects in negative regulation of cellular component organization can contribute to immune dysregulation and allergic inflammation. This underscores the broad relevance of this GO term beyond classical structural biology.
From negative regulation of cellular component organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PXN knockout impair focal adhesion disassembly? | CRISPR knockout in HeLa or MDA-MB-231 cells |
| Can a point mutation in CCN1 alter collagen alignment? | CRISPR point mutation knock-in in cardiac fibroblasts |
| Does NOTCH1 overexpression inhibit cellular organization? | CRISPR overexpression in cervical cancer cells |
| How does PER1 knockout affect circadian chromatin organization? | CRISPR knockout in U2OS circadian reporter cells |
| Does CCL21 knock-in restore tertiary lymphoid structures? | CRISPR knock-in in melanoma mouse models |
| Can MMP9 knockout prevent matrix disassembly? | CRISPR knockout in macrophage cell lines |
How to Study the negative regulation of cellular component organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Multiplexed ion beam imaging (MIBI) | Spatial distribution of proteins and cells | Tumor-immune microenvironment analysis |
| RNA-seq | Transcriptional changes | Identifying genes regulated by circadian chromatin |
| ChIP-seq | Chromatin occupancy | Mapping PER1/CRY1 binding sites |
| Proteomics | Protein abundance and modifications | Focal adhesion disassembly studies |
| CRISPR knockout screens | Gene function loss | Identifying negative regulators of organization |
| CRISPR activation screens | Gene overexpression | Discovering inhibitors of cellular organization |
| Live-cell imaging | Dynamic structural changes | Focal adhesion turnover and migration |
| Western blot | Protein expression and phosphorylation | Validating signaling changes |
Imaging-based analysis of cellular organization
Multiplexed ion beam imaging (MIBI) allows spatial visualization of tumor-immune microenvironments and quantification of cellular organization at single-cell resolution. This method is ideal for studying how negative regulation of cellular component organization affects immune cell positioning and tissue architecture.
Transcriptomic and epigenomic profiling
RNA-seq and ChIP-seq can identify genes and chromatin regions regulated by negative regulators of cellular organization. Circadian chromatin studies have used these methods to show that PER1 and CRY1 repress cytoskeletal genes in a time-dependent manner.
Proteomic analysis of focal adhesions
Mass spectrometry-based proteomics of isolated focal adhesions can reveal how paxillin interactions change during disassembly. This approach identifies phosphorylation events and protein complexes that execute negative regulation.
Functional CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of cellular component organization. Such screens have been used to discover genes that modulate immune cell infiltration and tumor architecture.
How CRISPR Can Be Used to Study GO:0051129 negative regulation of cellular component organization
Knockout
CRISPR knockout is used to eliminate genes such as PXN or NOTCH1 to determine whether they are required for negative regulation of cellular component organization. For example, PXN knockout in cancer cell lines leads to impaired focal adhesion disassembly and increased cell spreading. NOTCH1 knockout in cervical cancer cells can alter cellular organization and proliferation.
Point Mutation
CRISPR point mutation knock-in allows precise modification of phosphorylation sites or catalytic residues. For instance, mutating specific tyrosine residues in paxillin can block its interaction with downstream effectors, revealing their role in negative regulation. Similarly, point mutations in CCN1 can disrupt its matrix-binding activity and affect collagen alignment.
Knock-in
CRISPR knock-in of reporter tags or disease-associated alleles enables tracking of protein localization and function. Tagging endogenous CCN1 with fluorescent proteins allows real-time imaging of its role in scar integrity after myocardial infarction. Knock-in of CCL21 in melanoma models can restore tertiary lymphoid structure formation and enhance antitumor immunity.
Overexpression
CRISPR overexpression (e.g., via CRISPRa) is used to increase gene expression and test gain-of-function effects. Overexpressing NOTCH1 in cervical cancer cells can inhibit cellular organization and reduce invasive capacity. Overexpressing PER1 in circadian reporter cells can enhance repression of cytoskeletal genes.
How EDITGENE Supports negative regulation of cellular component organization Research
Researchers studying negative regulation of cellular component organization-related genes often need to determine whether a candidate gene is causally involved in structural remodeling, immune evasion, or disease progression. EDITGENE provides comprehensive CRISPR gene editing services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cellular component organization research.
Frequently Asked Questions About negative regulation of cellular component organization
What is GO:0051129?
GO:0051129 is the Gene Ontology term for negative regulation of cellular component organization, describing any process that stops, prevents, or reduces the frequency, rate, or extent of cellular component organization.
What genes are involved in negative regulation of cellular component organization?
Key genes include PXN, CCN1, NOTCH1, PER1, CRY1, and CCL21, among others, as reported in published literature.
How is negative regulation of cellular component organization studied?
Researchers use CRISPR knockout, point mutation, knock-in, overexpression models combined with imaging, proteomics, and transcriptomics.
What diseases are linked to negative regulation of cellular component organization?
It is linked to cancer progression, cardiovascular fibrosis, neuromuscular disorders, and primary atopic disorders.
What is the role of paxillin in this process?
Paxillin scaffolds focal adhesion disassembly and its interactions are critical for negative regulation of cellular component organization.
How does CCN1 regulate cellular organization?
CCN1 promotes collagen alignment and scar integrity after myocardial infarction, modulating matrix organization.
Can CRISPR screens identify new regulators of this process?
Yes, genome-wide CRISPR knockout and activation screens have identified novel regulators of cellular organization in tumor and immune contexts.
What is the difference between positive and negative regulation of cellular component organization?
Positive regulation promotes organization, while negative regulation stops or reduces it; GO:0051129 specifically covers the inhibitory processes.
How does circadian rhythm affect cellular component organization?
Circadian chromatin regulators such as PER1 and CRY1 repress genes involved in cytoskeletal organization, imposing temporal control.
What model systems are used to study negative regulation of cellular component organization?
Common models include cancer cell lines, cardiac fibroblasts, melanoma mouse models, and circadian reporter cell lines.
Conclusion
GO:0051129, negative regulation of cellular component organization, is a fundamental biological process that controls when and where cells stop building or dismantling their structures. Its dysregulation contributes to cancer, fibrosis, neuromuscular disorders, and immune dysfunction, making it a high-value target for therapeutic intervention. By leveraging CRISPR gene editing and advanced imaging, researchers can dissect the molecular players and pathways that execute this negative regulation, paving the way for novel treatments.
References
- 1. Keren L et al.. 2018. A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging.. Cell 174(6):1373-1387.e19 PMID: 30193111
- 2. Niehues T et al.. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.. Allergol Select 8:304-323 PMID: 39381601
- 3. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 4. Vats K et al.. 2022. Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune Responses.. Cancer Immunol Res 10(9):1141-1154 PMID: 35834791
- 5. Turner CE. 2000. Paxillin interactions.. J Cell Sci 113 Pt 23:4139-40 PMID: 11069756
- 6. Zhu Q et al.. 2020. Molecular Regulation of Circadian Chromatin.. J Mol Biol 432(12):3466-3482 PMID: 31954735
- 7. Rodrigues C et al.. 2019. Notch signalling in cervical cancer.. Exp Cell Res 385(2):111682 PMID: 31634483
- 8. Fischer AG et al.. 2024. Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction.. Matrix Biol 133:14-32 PMID: 39098433
